| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017583 |
| Receipt No. | R000020377 |
| Official scientific title of the study | Endoscopic slip knot clip suturing method: A clinical feasibility study |
| Date of disclosure of the study information | 2015/05/22 |
| Last modified on | 2016/05/16 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Endoscopic slip knot clip suturing method:
A clinical feasibility study |
|
| Title of the study (Brief title) | Slip knot clip suturing method | |
| Region |
|
|
| Condition | ||
| Condition | Colonic and duosenal ESD-induced ulcer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to analyze efficacy of slip knot clip suturing method. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Success rate |
| Key secondary outcomes | Procedure time, bleeding rate, perforation rate |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | ESD-induced ulcer is completely closed by slip knot clip suturing method. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who undergo colonic or duodenal ESD are included. | |||
| Key exclusion criteria | (1) allergy to polyester
(2) presence of clinically significant underlying disease (hepatic or renal disease) (3) pregnancy or nursing (4) ineligibility for treatment as determined by a physician |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Toshihiro Nishizawa |
| Organization | Keio University School of Medicine |
| Division name | Division of Research and Development for Minimally Invasive Treatment, Cancer Center |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| nisizawa@kf7.so-net.ne.jp | |
| Public contact | |
| Name of contact person | Toshihiro Nishizawa |
| Organization | Keio University School of Medicine |
| Division name | Division of Research and Development for Minimally Invasive Treatment, Cancer Center |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| Homepage URL | |
| nisizawa@kf7.so-net.ne.jp | |
| Sponsor | |
| Institute | Keio University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Keio University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020377 |